It's a wrap! THANK YOU to everyone who joined us at the Connecticut Rare Disease Forum yesterday! Our dynamic community of researchers, advocates, industry leaders, and policymakers is driving meaningful change for rare disease patients and their families. What was YOUR favorite part of the event? Comment below! We would also like to extend special thanks to: Our speakers and participating organizations: ? Lon Cardon, Ph.D., The Jackson Laboratory ? Cat Lutz, Ph.D., The Jackson Laboratory Rare Disease Translational Center ? Mark Adams, Ph.D., The Jackson Laboratory ? Angela Cacace, Ph.D., CSO, Arvinas ? Tom Defay, Ph.D., Alexion Pharmaceuticals, Inc. ? Birgit Fogal, Ph.D., Boehringer Ingelheim ? Rebecca Riba-Wolman, M.D., Connecticut Children's, University of Connecticut Medical School ? Jodie Sherman Gillon, BioCT ? Michael Aberman, MD, Regeneron Ventures ? Monica Coenraads, Rett Syndrome Research Trust ? Pamela Gavin, National Organization for Rare Disorders (NORD) ? Nicholas Vita, Apriligen, Inc. ? Senator Tony Hwang, Connecticut General Assembly Our host and partner: The Jackson Laboratory Our sponsors: Alexion Pharmaceuticals, Inc., Boehringer Ingelheim, Illumina, PacBio, Thermo Fisher Scientific,?Wiggin and Dana LLP, OrphAI Therapeutics, GeneDx, and Vertex Pharmaceuticals. ? #RareDisease #ConnecticutRareDisease #RareDiseaseForum #ClinicalTranslation #LifeSciences #BiotechEvents
-
-
-
-
-
+13